Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
letter
. 1970 Jan 10;1(5688):89–92. doi: 10.1136/bmj.1.5688.89

Experimental and Clinical Studies on Rifampicin in Treatment of Leprosy

R J W Rees, J M H Pearson, M F R Waters
PMCID: PMC1699176  PMID: 4903972

Abstract

Rifampicin showed high activity against experimental leprosy, inhibiting the multiplication of dapsone-sensitive and dapsone-resistant strains of Mycobacterium leprae in mice fed 5 mg./kg. body weight. In a formal pilot-type trial on six previously untreated patients with active lepromatous leprosy, rifampicin (600 mg. daily by mouth) was as effective as standard treatment with dapsone. Myco. leprae, however, appeared to be killed more rapidly by rifampicin than by dapsone or other antileprosy drugs so far studied. This was confirmed on a further 10 patients, including two with dapsone resistance, and from the infectivity in mice of bacilli recovered from patients during treatment with rifampicin or dapsone. These results are consistent with the bactericidal activity of rifampicin against other micro-organisms, which could be important to the chemotherapy of leprosy, since all antileprosy drugs in current use are bacteriostatic.

Full text

PDF
89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Canetti G., Le Lirzin M., Porven G., Rist N., Grumbach F. Some comparative aspects of rifampicin and isoniazid. Tubercle. 1968 Dec;49(4):367–376. doi: 10.1016/s0041-3879(68)80017-0. [DOI] [PubMed] [Google Scholar]
  2. Grumbach F., Rist N. Activité antituberculeuse expérimentale de la rifampicine, dérivé de la rifamycine SV. Rev Tuberc Pneumol (Paris) 1967 Sep-Oct;31(6):749–762. [PubMed] [Google Scholar]
  3. HART P. D., REES R. J., VALENTINE R. C. Isoniazid resistant and dependent strains of Mycobacterium lepraemurium studied in vivo and vitro. J Pathol Bacteriol. 1962 Jul;84:105–111. doi: 10.1002/path.1700840112. [DOI] [PubMed] [Google Scholar]
  4. Hartmann G., Honikel K. O., Knüsel F., Nüesch J. The specific inhibition of the DNA-directed RNA synthesis by rifamycin. Biochim Biophys Acta. 1967;145(3):843–844. doi: 10.1016/0005-2787(67)90147-5. [DOI] [PubMed] [Google Scholar]
  5. Maggi N., Pasqualucci C. R., Ballotta R., Sensi P. Rifampicin: a new orally active rifamycin. Chemotherapy. 1966;11(5):285–292. doi: 10.1159/000220462. [DOI] [PubMed] [Google Scholar]
  6. Pettit J. H., Rees R. J. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study. Int J Lepr Other Mycobact Dis. 1967 Apr-Jun;35(2):140–148. [PubMed] [Google Scholar]
  7. Pettit J. H., Rees R. J., Ridley D. S. Studies on sulfone resistance in leprosy. I. Detection of cases. Int J Lepr Other Mycobact Dis. 1966 Oct-Dec;34(4):375–390. [PubMed] [Google Scholar]
  8. REES R. J. LIMITED MULTIPLICATION OF ACID-FAST BACILLI IN THE FOOT-PADS OF MICE INOCULATED WITH MYCOBACTERIUM LEPRAE. Br J Exp Pathol. 1964 Apr;45:207–218. [PMC free article] [PubMed] [Google Scholar]
  9. Rees R. J. Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature. 1966 Aug 6;211(5049):657–658. doi: 10.1038/211657a0. [DOI] [PubMed] [Google Scholar]
  10. Rees R. J. New prospects for the study of leprosy in the laboratory. Bull World Health Organ. 1969;40(5):785–800. [PMC free article] [PubMed] [Google Scholar]
  11. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  12. SENSI P., MARGALITH P., TIMBAL M. T. Rifomycin, a new antibiotic; preliminary report. Farmaco Sci. 1959;14(2):146–147. [PubMed] [Google Scholar]
  13. Shepard C. C., Levy L., Fasal P. The death of Mycobacterium leprae during treatment with 4,4'-diaminodiphenylsulfone (DDS). Initial rate in patients. Am J Trop Med Hyg. 1968 Sep;17(5):769–775. doi: 10.4269/ajtmh.1968.17.769. [DOI] [PubMed] [Google Scholar]
  14. WATERS M. F. CHEMOTHERAPEUTIC TRIALS IN LEPROSY. 1. COMPARATIVE TRIAL OF MACROCYCLON PLUS DAPSONE AND DAPSONE ALONE IN THE TREATMENT OF LEPROMATOUS LEPROSY. Lepr Rev. 1963 Oct;34:173–192. [PubMed] [Google Scholar]
  15. Waters M. F., Pettit J. H. Chemotherapeutic trials in leprosy. 2. Comparative trial of dapsone plus ditophal (Etisul) and dapsone alone in the treatment of lepromatous leprosy. Int J Lepr. 1965 Jul-Sep;33(3):280–296. [PubMed] [Google Scholar]
  16. Waters M. F., Rees R. J., Sutherland I. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1967 Jul-Sep;35(3):311–335. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES